Drug development is a complex process that inherently involves intricate challenges. Introduction of new regulatory policies, cutting-edge technologies, and evolving perspectives on animal research are reshaping strategies in drug development. Please join us for an interactive lunchtime seminar where we will discuss opportunities for strategy refinement to: 

• Enhance chances of clinical success during the drug discovery phase
• Leverage in vivo pharmacology for proof-of-concept data
• Adopt new technologies to accelerate timelines
• Focus on key elements in your IND strategy
• Maximize your relationship with your CRO

Lunch will be provided for attendees. 

1-on-1 meetings (1-3pm): Following the talk, Samuel will have limited sessions available for 1-on-1 meetings with faculty interested in discussing their drug development in greater detail. Please sign up via the registration link.